Arisan Therapeutics

About:

Arisan Therapeutics is a life science company that develops novel solutions for the treatment of neglected and emerging infectious diseases.

Website: http://www.arisanthera.com/

Top Investors: National Institute of Allergy and Infectious Diseases

Description:

Arisan Therapeutics develops therapeutics for neglected and emerging viral diseases. They offer infectious diseases that have the potential for significant impact on public health and have been classified as priority biodefense-related pathogens.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2010-01-01

Founders:

Greg Henkel, Ken McCormack

Number of Employees:

1-10

Last Funding Date:

2019-06-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai